155 related articles for article (PubMed ID: 28869598)
1. RCC2 is a novel p53 target in suppressing metastasis.
Song C; Liang L; Jin Y; Li Y; Liu Y; Guo L; Wu C; Yun CH; Yin Y
Oncogene; 2018 Jan; 37(1):8-17. PubMed ID: 28869598
[TBL] [Abstract][Full Text] [Related]
2. RCC2 over-expression in tumor cells alters apoptosis and drug sensitivity by regulating Rac1 activation.
Wu N; Ren D; Li S; Ma W; Hu S; Jin Y; Xiao S
BMC Cancer; 2018 Jan; 18(1):67. PubMed ID: 29321004
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.
Humphries JD; Byron A; Bass MD; Craig SE; Pinney JW; Knight D; Humphries MJ
Sci Signal; 2009 Sep; 2(87):ra51. PubMed ID: 19738201
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
5. Coronin-1C and RCC2 guide mesenchymal migration by trafficking Rac1 and controlling GEF exposure.
Williamson RC; Cowell CA; Hammond CL; Bergen DJ; Roper JA; Feng Y; Rendall TC; Race PR; Bass MD
J Cell Sci; 2014 Oct; 127(Pt 19):4292-307. PubMed ID: 25074804
[TBL] [Abstract][Full Text] [Related]
6. RCC2, a regulator of the RalA signaling pathway, is identified as a novel therapeutic target in cisplatin-resistant ovarian cancer.
Gong S; Chen Y; Meng F; Zhang Y; Wu H; Li C; Zhang G
FASEB J; 2019 Apr; 33(4):5350-5365. PubMed ID: 30768358
[TBL] [Abstract][Full Text] [Related]
7. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
[TBL] [Abstract][Full Text] [Related]
8. Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer.
Bruun J; Kolberg M; Ahlquist TC; Røyrvik EC; Nome T; Leithe E; Lind GE; Merok MA; Rognum TO; Bjørkøy G; Johansen T; Lindblom A; Sun XF; Svindland A; Liestøl K; Nesbakken A; Skotheim RI; Lothe RA
Clin Cancer Res; 2015 Aug; 21(16):3759-70. PubMed ID: 25910952
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
Ye YP; Jiao HL; Wang SY; Xiao ZY; Zhang D; Qiu JF; Zhang LJ; Zhao YL; Li TT; Li-Liang ; Liao WT; Ding YQ
J Exp Clin Cancer Res; 2018 Dec; 37(1):299. PubMed ID: 30514346
[TBL] [Abstract][Full Text] [Related]
10. RCC2 promotes prostate cancer cell proliferation and migration through Hh/GLI1 signaling pathway and cancer stem-like cells.
Wang S; Lei Z; Liu W; Xiong J; Shi Y; Yang L; Gao Q; Le K; Zhang B
Biol Direct; 2023 Nov; 18(1):80. PubMed ID: 38008751
[TBL] [Abstract][Full Text] [Related]
11. MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2.
Matsuo M; Nakada C; Tsukamoto Y; Noguchi T; Uchida T; Hijiya N; Matsuura K; Moriyama M
Mol Cancer; 2013 Feb; 12():15. PubMed ID: 23442884
[TBL] [Abstract][Full Text] [Related]
12. Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis.
Zhang C; Liu J; Zhao Y; Yue X; Zhu Y; Wang X; Wu H; Blanco F; Li S; Bhanot G; Haffty BG; Hu W; Feng Z
Elife; 2016 Jan; 5():e10727. PubMed ID: 26751560
[TBL] [Abstract][Full Text] [Related]
13. Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.
Yi JM; Kang EJ; Kwon HM; Bae JH; Kang K; Ahuja N; Yang K
Oncotarget; 2017 Apr; 8(16):26600-26612. PubMed ID: 28460450
[TBL] [Abstract][Full Text] [Related]
14. Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation.
Li Y; Zhao M; Guo C; Chu H; Li W; Chen X; Wang X; Li Y; Jia Y; Koussatidjoa S; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen W; Zhang L
Oncogene; 2018 Feb; 37(8):1095-1106. PubMed ID: 29106392
[TBL] [Abstract][Full Text] [Related]
15. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
16. RCC2 Promotes Esophageal Cancer Growth by Regulating Activity and Expression of the Sox2 Transcription Factor.
Calderon-Aparicio A; Yamamoto H; De Vitto H; Zhang T; Wang Q; Bode AM; Dong Z
Mol Cancer Res; 2020 Nov; 18(11):1660-1674. PubMed ID: 32801160
[TBL] [Abstract][Full Text] [Related]
17. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
[TBL] [Abstract][Full Text] [Related]
18. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer.
Gómez del Pulgar T; Bandrés E; Espina C; Valdés-Mora F; Pérez-Palacios R; García-Amigot F; García-Foncillas J; Lacal JC
Int J Biochem Cell Biol; 2007; 39(12):2289-302. PubMed ID: 17766170
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1.
Worthylake DK; Rossman KL; Sondek J
Nature; 2000 Dec; 408(6813):682-8. PubMed ID: 11130063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
